The mission of the Medical Scientist Training Program (MSTP) of the Albert Einstein College of Medicine is to train physician-scientists who will become future leaders in biomedical and clinical research. It strives to recruit a diverse group of outstanding students and to provide them with rigorous combined medical and research training that prepares them for careers as physician-scientists. Through a flexible and continuously evolving curriculum that includes 1) specialized MSTP courses and 2) integration of grad and med school curriculum in the first 2 years, the students are guided through a program that can be tailored to meet their individual needs and interests. The program seeks to provide the trainees with a unique foundation for careers as independent physician-scientists and to facilitate their placement into outstanding postgraduate training programs to facilitate the next step in their career progression. The training program has 3 phases. In the first 2 years students take an integrated combination of medical, graduate and MSTP-specific courses to provide the didactic foundation for their research and clinical training. They perform research rotations to assist them in choosing their thesis research lab. In the program's 2nd phase, they perform independent, original research under their mentor's guidance. They publish their discoveries in high quality peer reviewed papers and prepare and defend a Ph.D. thesis. Participation in an evening, MSTP-run, ambulatory outpatient clinic allows them to build their clinical skills during the PhD phase of the program. In the final phase, they complete their clinical training on the wards. The admissions process seeks to identify individuals with the intelligence, curiosity, creativity, perseverance and enthusiasm for science that is essential for future success in a research career. 117 trainees are in the program, 43% are woman and 14% are members of underrepresented minorities. Since its inception in 1964 as one of the first three NIH funded MD-PhD training programs, 359 trainees have graduated. 277 have completed postgraduate training and published over 14,611 papers, an average of 53 papers per graduate. 82% have jobs at academic medical centers, research institutes, NIH or pharmaceutical companies. By various measures, the program graduates have achieved outstanding success in their chosen careers and have contributed to the advancement of biomedical research and academic medicine. Based on the quality of our past accomplishments, we propose to expand the program, to further integrate graduate and medical training, and increase opportunities for involvement in clinical and translational research in order to prepare a future generation of physician-scientists who will be at the leading edge of biomedical research with the ultimate goal of improving human health and reducing the burden of disease.

Public Health Relevance

physician-scientists perform a critical role at the interface between basic biomedical research and clinical medicine. This program will train a diverse group of highly skilled physician-scientists who will facilitate the process of scientific discovery that aims to reduce the burden o disease for all Americans. PUBLIC HEALTH RELEVANCE: This program will train a diverse group of outstanding students and prepare them to enter the biomedical research workforce as physician-scientists who will perform basic, translational and clinical research. This research will lead to new treatments to prevent or cure disease and improve the health of all Americans.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007288-44
Application #
9307860
Study Section
Special Emphasis Panel (ZGM1)
Program Officer
Maas, Stefan
Project Start
1975-07-01
Project End
2018-06-30
Budget Start
2017-07-01
Budget End
2018-06-30
Support Year
44
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine, Inc
Department
Type
DUNS #
079783367
City
Bronx
State
NY
Country
United States
Zip Code
10461
Kaufman, Odelya H; Lee, KathyAnn; Martin, Manon et al. (2018) rbpms2 functions in Balbiani body architecture and ovary fate. PLoS Genet 14:e1007489
Cabrera, Ramon M; Mao, Serena P H; Surve, Chinmay R et al. (2018) A novel neuregulin - jagged1 paracrine loop in breast cancer transendothelial migration. Breast Cancer Res 20:24
Chalmers, Samantha A; Wen, Jing; Doerner, Jessica et al. (2018) Highly selective inhibition of Bruton's tyrosine kinase attenuates skin and brain disease in murine lupus. Arthritis Res Ther 20:10
Mike, Elise V; Makinde, Hadijat M; Der, Evan et al. (2018) Neuropsychiatric Systemic Lupus Erythematosus Is Dependent on Sphingosine-1-Phosphate Signaling. Front Immunol 9:2189
Zamurrad, Sumaira; Hatch, Hayden A M; Drelon, Coralie et al. (2018) A Drosophila Model of Intellectual Disability Caused by Mutations in the Histone Demethylase KDM5. Cell Rep 22:2359-2369
Kerner-Rossi, Mallory; Gulinello, Maria; Walkley, Steven et al. (2018) Pathobiology of Christianson syndrome: Linking disrupted endosomal-lysosomal function with intellectual disability and sensory impairments. Neurobiol Learn Mem :
Carvajal, Luis A; Neriah, Daniela Ben; Senecal, Adrien et al. (2018) Dual inhibition of MDMX and MDM2 as a therapeutic strategy in leukemia. Sci Transl Med 10:
Schloss, Jennifer; Ali, Riyasat; Racine, Jeremy J et al. (2018) HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression. J Immunol 200:3353-3363
Zheng, Zengming; Wang, Zhou-Guang; Chen, Yu et al. (2018) Spermidine promotes nucleus pulposus autophagy as a protective mechanism against apoptosis and ameliorates disc degeneration. J Cell Mol Med 22:3086-3096
Dowling, Samuel D; Macian, Fernando (2018) Autophagy and T cell metabolism. Cancer Lett 419:20-26

Showing the most recent 10 out of 721 publications